The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?-Reference-Cited by-同舟云学术

The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?

Published:2014-06-16 Issue:1 Volume:56 Page:128-134
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Zeidner Joshua F.,Zahurak Marianna,Rosner Gary L.,Gocke Christopher D.,Jones Richard J.,Smith B. Douglas

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.910868

Reference31 articles.

1. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

2. Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

3. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

4. The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia—a report from the German Registry covering the period from 1998 to 2004

5. Role of Allogeneic Stem Cell Transplantation for Adult Chronic Myeloid Leukemia in the Imatinib Era

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations;Leukemia;2023-01-27

2. Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape;Leukemia;2021-04-08

3. Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies;Journal of Clinical Oncology;2021-02-10

4. CML Chapter;Cancer Treatment and Research;2021

5. Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia: What is the Best Strategy?;Biology of Blood and Marrow Transplantation;2020-09